Afficher la notice abrégée

dc.contributor.authorFalcoff, Efr_FR
dc.contributor.authorBernabo, Jfr_FR
dc.contributor.authorBottasso, Ofr_FR
dc.date.accessioned2013-02-18T16:16:55Z
dc.date.available2013-02-18T16:16:55Z
dc.date.issued1993fr_FR
dc.identifier.citationFalcoff, E ; Bernabo, J ; Bottasso, O, L'interféron γ transforme le pronostic des patients atteints de Leishmaniose chimiorésistante., Med Sci (Paris), 1993, Vol. 9, N° 11; p.1214-7.fr_FR
dc.identifier.issn1958-5381fr_FR
dc.identifier.urihttp://hdl.handle.net/10608/2834
dc.description.abstractT lymphocytes from patients with visceral leishmaniasis treated in vitro with leishmania antigens are unable to proliferate and to produce γ interferon. These patients have negative specific skin tests. Opposite results are obtained in patients with another clinical form of the disease named mucocutaneous leishmaniasis, in which both tests are positive. Nevertheless, patients with visceral leishmaniasis or mucocutaneous leishmaniasis, refractory to chemotherapy (antimonium complex), were cured when antimonium in combination with gamma interferon, in spite of different immunological profiles. Different interpretative hypotheses of the reversion of chemoresistance induced by γ interferon are discussed.fr
dc.language.isofrfr_FR
dc.publisherJohn Libbey Eurotext, Montrougefr_FR
dc.rightsArticle en libre accèsfr
dc.rightsMédecine/Sciences - Inserm - SRMSfr
dc.sourceM/S. Médecine sciences [revue papier, ISSN : 0767-0974], 1993, Vol. 9, N° 11; p.1214-7.fr_FR
dc.titleL'interféron γ transforme le pronostic des patients atteints de Leishmaniose chimiorésistante.fr
dc.typeArticlefr_FR
dc.identifier.doi10.4267/10608/2834


Fichier(s) constituant ce document

Thumbnail
Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée